Search results

Evidence-based recommendations on Xeomin (botulinum neurotoxin type A) for treating chronic sialorrhoea (excessive salivation and drooling) caused by neurological conditions in adults.

Result type

Technology appraisal guidance

Published

9 October 2019

This guideline covers how to identify the adults, young people and children with non-alcoholic fatty liver disease (NAFLD) who have advanced liver fibrosis and are most at risk of further complications. It outlines the lifestyle changes and pharmacological treatments that can manage NAFLD and advanced liver fibrosis.

Result type

NICE guideline

Published

6 July 2016

Evidence-based recommendations on coil embolisation of ruptured intracranial aneurysms. This involves passing a thin tube through the body to place coils inside the aneurysm.

Result type

Interventional procedures guidance

Published

26 January 2005

This quality standard covers diagnosing, monitoring and managing any type of primary brain tumour or brain metastases in adults (aged 16 or over). It describes high-quality care in priority areas for improvement.

Result type

Quality standard

Published

7 December 2021

Evidence-based recommendations on icosapent ethyl (Vazkepa) with statin therapy for reducing the risk of cardiovascular events in adults with raised triglycerides.

Result type

Technology appraisal guidance

Published

13 July 2022

Evidence-based recommendations on belzutifan (Welireg) for treating tumours associated with von Hippel-Lindau disease in adults.

Result type

Technology appraisal guidance

Published

16 October 2024

Evidence-based recommendations on solriamfetol (Sunosi) for treating excessive daytime sleepiness caused by obstructive sleep apnoea in adults.

Result type

Technology appraisal guidance

Published

9 March 2022

The medtech innovation briefing on Cerebrotech Visor for detecting stroke has been withdrawn as the technology is no longer available in the NHS.

Result type

Medtech innovation briefing

Published

12 December 2018

NICE has a developed medtech innovation briefing on Mollii suit for spasticity .

Result type

Medtech innovation briefing

Published

28 March 2017

Evidence-based recommendations on alirocumab (Praluent) for treating primary hypercholesterolaemia or mixed dyslipidaemia in adults.

Result type

Technology appraisal guidance

Published

22 June 2016

Evidence-based recommendations on implanting a baroreceptor stimulation device for resistant hypertension. This involves using electrical impulses from the device that stimulate baroreceptors to help the body lower blood pressure.

Result type

Interventional procedures guidance

Published

28 October 2015

This guideline covers planning and delivering social care and support for older people who have multiple long-term conditions. It promotes an integrated and person-centred approach to delivering effective health and social care services.

Result type

NICE guideline

Published

4 November 2015

Evidence-based recommendations on deep brain stimulation for Parkinson's disease. This involves planting electrodes into the brain and generating electrical currents to reduce the problems caused by Parkinson's disease.

Result type

Interventional procedures guidance

Published

26 November 2003

Summary of the evidence on oral glycopyrronium bromide for treating hyperhidrosis (excessive sweating) to inform local NHS planning and decision-making

Result type

Evidence summary

Published

9 July 2013

Evidence-based recommendations on short-term circulatory support with left ventricular assist devices (LVAD) as a bridge to heart transplantation or recovery. This involves inserting a mechanical device into the chest to help the heart pump blood around the body.

Result type

Interventional procedures guidance

Published

28 June 2006